Tardive Dyskinesia in Bipolar Disorders: Possible Role of Pineal Melatonin

References

• Aldegunde M., Miqucz I., Vcira J. Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience 1985; 26: 9–13
   PubMed Web of Science ®Google Scholar
• Anton-Tay F. Melatonin: effects on brain function. Advances in Biochemical Psychoplwrmacology 1974; 11: 315–324
   PubMedGoogle Scholar
• Anton-Tay I., Chou C., Anton S., Wurtman R. J. Brain serotonin concentrations: elevation following intraperitoneal administration of melatonin. Science 1968; 162: 277–278
   PubMed Web of Science ®Google Scholar
• Anton-Tay F., Diaz J. L., Fernandez-Guardiola A. On the effect of melatonin upon human brain. Its possible therapeutic implications. Life Science 1971; 10: 841–850
   Web of Science ®Google Scholar
• Brown R., Kocsis J. II., Caroff S., Amsterdam J., Winokur A., Stokes P. E., Frazer A. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. American Journal of Psychiatry 1985; 142: 811–816
   PubMed Web of Science ®Google Scholar
• Cotzias G. C., Papavasiliou P. S., Ginos J. Z., Stcck A. J., Duby S. F. Metabolic modification of Parkinson's disease and of chronic manganese poisoning. Annual Review of Medicine 1971; 22: 305–326
   PubMed Web of Science ®Google Scholar
• Cutler N., Post R., Rey A., Bunney W. Depression-dependent dyskinesias in two cases of manic depressive illness. New England Journal of Medicine 1981; 304: 1088–1089
   PubMed Web of Science ®Google Scholar
• De Potter R. W., Linkowski P., Medlewicz J. State-dependent tardive dyskinesia in manic-depressive illness. Journal of Neurology Neurosurgery and Psychiatry 1983; 46: 666–668
   PubMed Web of Science ®Google Scholar
• Firlich S. S., Apuzzo M. L. J. The pineal gland: Anatomy, physiology and clinical significance. Journal of Neurosurgery 1985; 63: 321–341
   PubMedGoogle Scholar
• Fibiger H. C., Lloyd K. G. Neurobiological substates of tardive dyskinesia: the GABA hypothesis. Trends in Neurosciences 1984; 7: 462–464
   Web of Science ®Google Scholar
• Galdi J., Rieder R. O., Silber D., Bonato R. B. Genetic factors in the response to neuroleptics in schizophrenia: A psychopharmacogenetic study. Psychological medicine 1981; 11: 713–728
   PubMed Web of Science ®Google Scholar
• Gardos G., Casey D. E. Tardive dyskinesia and affective disorders. American Psychiatric Press Inc, Washington, DC 1983
   Google Scholar
• Gerner R., Post R., Bunney W. A dopaminergic mechanism of mania. American Journal of Psychiatry 1976; 133: 1177–1180
   PubMedGoogle Scholar
• Goswami U., Narayanan H. S., Channabasavanna S. M. A study of state-dependent reversal of tardive dyskinesia: Phenomenological probe in humans. Journal of Clinical Psvchopharmacology 1985; 5: 48–50
   PubMedGoogle Scholar
• Gunne L. M., Häggström J. E., Sjöquist B. Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Nature 1984; 309: 347–348
   PubMed Web of Science ®Google Scholar
• Hamra B. J., Nasrallah H. A., Clancy J., Finn R. Psychiatric diagnosis and risk for tardive dyskinesia. Archives of General Psychiatry 1983; 40: 346–347
   PubMed Web of Science ®Google Scholar
• Jeste D. V., Wyatt R. J. Dogma disputed: Is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?. Journal of Clinical Psychiatry 1981; 42: 455–457
   PubMed Web of Science ®Google Scholar
• Kane J. M., Woerner M., Lieberman J. Tardive dyskinesia: Prevalence, incidence, and risk factors. Journal of Clinical Psvchopharmacology 1988; 8: 52S–56S, (suppl)
   PubMed Web of Science ®Google Scholar
• Klawans H. L. The pharmacology of tardive dyskinesia. American Journal of Psychiatry 1973; 130: 82–86
   PubMed Web of Science ®Google Scholar
• Kopp N., Clastrat B., Tappaz M. Evidence for the presence of melatonin receptors in the human brain. Neuroscience Letters 1980; 19: 237–242
   PubMed Web of Science ®Google Scholar
• Kozell L., Sandyk R., Wagner G. C., Fisher H. The effects of L-tryptophan on haloperidol induced movement disorder in the rat. Life Sciences 1987; 41: 1739–1744
   PubMed Web of Science ®Google Scholar
• Lal K. P., Saxena S., Mohan D. Tardive dystonia alternating with mania. Biological Psychiatry 1988; 23: 312–316
   PubMed Web of Science ®Google Scholar
• Laudon M., Nir I., Zisapel N. Melatonin receptors in discrete brain areas of the male rat. Impact of aging on density and on circadian rhythmicity. Neuroendocrinology 1988; 48: 577–583
   PubMed Web of Science ®Google Scholar
• Lewy A. J., Kern H. A. Effects of light on human melatonin production and the human circadian system. Progress in Neuropsychopharmacologv and Biological Psychiatry 1983; 7: 551–556
   PubMed Web of Science ®Google Scholar
• Lewy A. J., Nurnberger J. I., Wehr T. A., Pack D., Becker L. E., Powell R. l., Newsome D. A. Supersensitivity to light: possible trait marker for manic-depressive illness. American Journal of Psychiatry 1985; 142: 725–727
   PubMed Web of Science ®Google Scholar
• Lewy A. J., Wehr T. A., Gold P., Goodwin F. K. Plasma melatonin in manic-depressive illness. Catecholamines: Basic and Clinical Frontiers, E. Usdin, I. J. Kopin, J. Barchas. Pergamon Press, New York 1979; vol 2: 1173–1175
   Google Scholar
• Lewy A. J., Wehr T. A., Goodwin F. K., Newsome D. A., Rosenthal N. E. Manic-depressive patients may be supersensitive to light. Lancet 1981; 1: 383–384
   PubMed Web of Science ®Google Scholar
• Lynch H. J., Wang P., Wurtman R. J. Increase in rat pineal melatonin content following L-dopa administration. Life Sciences 1973; 12: 145–151
   Web of Science ®Google Scholar
• Miles A., Philbrick D. R. S. Melatonin and psychiatry. Biological Psychiatry 1988; 23: 405–425
   PubMed Web of Science ®Google Scholar
• Mukherjee S., Rosen A. M., Caracci G., Shukla S. Persistent tardive dyskinesia in bipolar patients. Archives of General Psychiatry 1986; 43: 342–346
   PubMed Web of Science ®Google Scholar
• Papavasiliou P. S., Cotzias G. C., Duby S. E., Steck A. J., Bell M., Lawrence W. H. Melatonin and Parkinsonism. Journal of the American Medical Association 1972; 221: 88–89
   PubMed Web of Science ®Google Scholar
• Post R. M., Jimerson D. C., Bunney W. E., Goodwin F. K. Dopamine and mania: Behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology 1980; 67: 297–305
   PubMed Web of Science ®Google Scholar
• Post R. M., Lake C. R., Jimersson D. C., Bunney W. E., Wood J. H., Ziegler M. G., Goodwin F. K. Cerebrospinal fluid norepinephrine in affective illness. American Journal of Psychiatry 1978; 135: 907–912
   PubMed Web of Science ®Google Scholar
• Rush M., Diamond F., Alpert M. Depression on a risk factor in tardive dyskinesia. Biological Psychiatry 1982; 17: 387–392
   PubMed Web of Science ®Google Scholar
• Sack R. L., Lewy A. J. Desmethylimipramine treatment increases melatonin production in humans. Biological Psychiatry 1986; 21: 406–410
   PubMed Web of Science ®Google Scholar
• Sandyk R. Attenuation of reserpine-induced catalepsy by melatonin and the role of the opioid system. International Journal of Neuroscience 1989; 48: 297–301
   PubMed Web of Science ®Google Scholar
• Sandyk R., Bamford C. R., Khan I. L-tryptophan in neuroleptic-induced tardive dyskinesia. International Journal of Neuroscience 1988; 42: 127–130
   PubMed Web of Science ®Google Scholar
• Sandyk R., Consroe P. F., Lacono R. P. L-tryptophan in drug-induced movement disorders with insomnia. New England Journal of Medicine 1986; 314: 1257
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. Melatonin mediates the antidyskinetic effects of naloxone in tardive dyskinesia. Journal of Clinical Psychopharmacology 1989; 9: 147–148
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. The protective function of the pineal gland in tardive dyskinesia. International Journal of Neuroscience 1988; 43: 215–218
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. Increased incidence and severity of Neuroleptic – induced movement disorder in pinealec to mized rats. International Journal of Neuroscience 1989; 48: 303–308
   PubMed Web of Science ®Google Scholar
• Shaw K. M., Stern G. M., Sandler M. Melatonin and Parkinsonism. Lancet 1973; 1: 271
   PubMed Web of Science ®Google Scholar
• Silverstone T. Dopamine in manic depressive illness: A Pharmacological synthesis. Journal of Affective Disorders 1985; 8: 225–231
   PubMed Web of Science ®Google Scholar
• Souetre E., Salvati E., Belugou J. L., Robert P., Brunet G., Darcourt G. Antidepressant effect of 5-methoxypsoralen: A preliminary report. Psychopharmacology 1988; 95: 430–431
   PubMed Web of Science ®Google Scholar
• Souetre E., Salvati E., Pringuey D., Brunet G., Savelli M., Krebs B., Darcourt G. Rythme circadien de la melatonine dans la depression: Etude transversale et logitudinale. Actual Psychiatriques 1986; 5: 88–93
   Google Scholar
• Vine P. A., Harthe C., Lestage P., Claustrat B., Bobillier P. Plasma, cerebrospinal fluid, and brain distribution of 14C-melatonin in rat: A biochemical and autoradiographic study. Journal of Pineal Research 1988; 5: 437–453
   PubMed Web of Science ®Google Scholar
• Wehr T. A., Goodwin F. K. Desynchronization of circadian rhythms as possibe source of manic-depressive cycles. Psychopharmacology Bulletin 1988; 16: 19–20
   Google Scholar
• Weiner W., Werner I. Mania induced remission of tardive dyskinesia in manic-depressive illness. Annals of Neurology 1982; 12: 229–230
   PubMed Web of Science ®Google Scholar
• Wetterberg L., Aperia B., Beck-Friis J. Melatonin and Cortisol levels in psychiatric illness. Lancet 1982; 2: 100
   PubMed Web of Science ®Google Scholar
• Wetterberg L., Beck-Friis J., Aperia B. Melatonin Cortisol ratio in depression. Lancet 1979; 2: 1361
   Web of Science ®Google Scholar
• Willner P. Dopamine and depression: A review of recent evidence. Brain Research Reviews 1983; 287: 211–218
   Google Scholar
• Wolf M. E., Almy G., Toll M., Mosnaim A. D. Mania associated with the use of baclofen. Biological Psychiatry 1982; 17: 757–759
   PubMed Web of Science ®Google Scholar
• Yassa R., Ghadirian A. M., Schwartz G. Prevalence of tardive dyskinesia in affective disorder patients. Journal of Clinical Psychiatry 1984; 44: 410–412
   Web of Science ®Google Scholar
• Zisapel N., Laudon M. Dopamine release induced by electrical field stimulation of rat hypothalamus in vitro inhibition by melatonin. Biochemistry Biophysics Research communications 1982; 104: 1610–1616
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Inhibition of dopamine release by melatonin: Regional distribution in the rat brain. Brain Research 1982; 24: 161–163
   Google Scholar
• Zisapel N., Nir I., Laudon M. Circadian variations in melatonin-binding sites in discrete areas of the male rat brain. FEBS Letters 1988; 232: 172–176
   PubMed Web of Science ®Google Scholar